PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Houston Methodist among largest providers of monoclonal antibody treatment for COVID-19

Strategy for successful mAB treatment program published in New England Journal of Medicine

2021-04-01
(Press-News.org) Houston Methodist has been a leader in successfully treating high-risk patients with monoclonal antibodies (mAB) for mild to moderate Covid-19 infection. Among the nation's largest providers of mAB therapy, Houston Methodist has infused nearly 4,000 patients since the FDA's Emergency Use Authorization (EUA) was issued. The hospital system was able to quickly ramp up its program once the EUA was granted by leveraging a number of resources through interdisciplinary collaboration.

As more hospitals begin to ramp up for treating Covid-19 with mAB therapy, Houston Methodist's example serves as a valuable model for other medical systems to establish or expand mAB treatment programs and improve patient access to this critical therapy. A commentary outlining the challenges, resources used and benchmarks of success published online March 29 in the New England Journal of Medicine Catalyst.

Houston Methodist drew upon its experience with clinical trials on other Covid-19 therapies and forged early partnerships with industry through the Houston Methodist Research Institute to conduct mAB clinical trials beginning early on in the pandemic. Doing so helped the hospital system overcome a number of obstacles to rapidly establish and scale up treatment clinics to bring mAB therapy to thousands of patients. Challenges included designing clinics using existing resources to separate Covid-19 positive patients from other hospitalized patients, establishing a referral stream that could treat large patient volumes and maintaining a sufficient drug supply to treat all patients.

Highlights included establishing six clinics in less than six weeks across the greater Houston area throughout Houston Methodist's system of hospitals; having an average of 1.2 days from referral to treatment; infusing more than 2,500 patients; and avoiding nearly 250 Covid-19-related hospitalizations. Some of these numbers have increased since the initial study period published in NEJM. Another mark of success, some patients have traveled as many as eight hours to receive mAB therapy at Houston Methodist. This also suggests a need for other healthcare systems to create or expand mAB infusion clinics to improve availability for those unable to travel.

INFORMATION:

The commentary authors reflect the breadth of specialties involved in creating Houston Methodist's successful mAB treatment infrastructure and include Nursing Director Jennifer R. Berry, D.N.P., R.N.; Director of System Clinical Pharmacy Services Michael G. Liebl Pharm.D.; System Director of Research Operations Pauline H. Todd, M.B.A., B.S.N., R.N.; and Chief Nursing Officer Vicki Brownewell, M.S., R.N.

To read the study, titled "Rapid Operationalization of Covid-19 Monoclonal Antibody Infusion Clinics," visit https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0040.

Citation: Rapid Operationalization of Covid-19 Monoclonal Antibody Infusion Clinics. New England Journal of Medicine. (online March 29, 2021) Jennifer R. Berry, Michael G. Liebl, Pauline H. Todd and Vicki Brownewell; DOI: https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0040



ELSE PRESS RELEASES FROM THIS DATE:

CU Cancer Center researcher reveals new effects of oxygen deprivation in cancer cells

CU Cancer Center researcher reveals new effects of oxygen deprivation in cancer cells
2021-03-31
A team of University of Colorado School of Medicine researchers recently published a paper offering new insight into the role that oxygen deprivation, or hypoxia, plays in cancer development. CU Cancer Center member Joaquin Espinosa, PhD, is the senior researcher on the paper, which he hopes will help lead to more targeted treatments for cancer.  For their paper published this month in the journal Nature Communications, Espinosa and the rest of the team -- Zdenek Andrysik, PhD; Heather Bender, PhD; and Matthew Galbraith, PhD -- used state-of-the-art genomics technologies to map the response of cancer cells to hypoxia with unprecedented detail, ...

Novel pharmacological strategies to treat alcoholism. Focus on epigenetics

Novel pharmacological strategies to treat alcoholism. Focus on epigenetics
2021-03-31
Abusive alcohol drinking considerably impacts human health. Alcoholism, better defined as Alcohol Use Disorders (AUD), includes a group of pathological entities related to alcohol-induced damage. Individuals with AUD exhibit compulsive alcohol drinking and negative emotional states when alcohol drinking ceases. In the most severe AUD forms, the individuals lose control over consumption despite a decided will to stop. Some controversial issues have arisen as to whether the definition of AUD can help to delimit and characterize clinical entities related to abusive alcohol ingestion. The World Health Organization (WHO) reports that approximately 3,3 million people (5,9% of global ...

COVID-19 antibody tests, even rapid finger pricks, are effective, new study finds

2021-03-31
New findings from a Michigan Medicine study reveal that antibody testing is predictive of prior COVID-19 infection, and rapid screening methods - even from finger pricks - are effective testing tools. Researchers analyzed antibody tests conducted on more than 500 subjects in patient care settings. They found that people who had COVID, including those with mild symptoms, produced antibodies. "For a long time, people were very worried that people with mild COVID did not make immune responses," says Charles Schuler, M.D., a clinical assistant professor of allergy and immunology at Michigan Medicine. "This should give people confidence that the tests that are available to them aren't just random number generators. They're actually giving them ...

Soft "sweat stickers" may streamline diagnosis of cystic fibrosis in children

2021-03-31
New "sweat stickers" may streamline the early diagnosis of cystic fibrosis by enabling scientists to easily gather and analyze sweat from the skin of infants and children. The stickers matched the performance of previous, more cumbersome devices when tested with 51 subjects, suggesting the stickers could address design obstacles that have held back the diagnosis and treatment of cystic fibrosis in pediatric patients. Diagnosing cystic fibrosis in infancy or childhood is critical to achieve good outcomes, as current treatments must be given early to extend lifespans and alter the course of the disease. Many current diagnostics work by detecting levels of chloride in sweat, which are elevated in cystic fibrosis patients. However, these tests must often be repeated and use unwieldy wrist-wrapped ...

Mothers bear the cost of the pandemic shift to remote work

2021-03-31
For many parents, the COVID-19 pandemic has made life's everyday juggling act--managing work, school, extracurricular, and household responsibilities--much, much harder. And according to a new study led by Penn sociologists, those extra burdens have fallen disproportionately on mothers. The research, shared in the April issue of the journal Gender and Society, investigated how shifts in work and school that arose due to the pandemic triggered changes in the division of labor in families. Using data on two-parent households from a nationwide survey conducted in April 2020, the researchers found that ...

A Skoltech method helps model the behavior of 2D materials under pressure

A Skoltech method helps model the behavior of 2D materials under pressure
2021-03-31
Scientists from the Skoltech Center for Energy Science and Technology (CEST) have developed a method for modeling the behavior of 2D materials under pressure. The research will help create pressure sensors based on silicene or other 2D materials. The paper was published in the ACS Nano journal. Silicene, which is regarded as the silicon analog of graphene, is a two-dimensional allotrope of silicon. In its normal state, bulk silicon is a semiconductor with a diamond crystal type structure. As it thins down to one or several layers, its properties change dramatically. However, it has not yet been possible to study the change in the electronic properties of 2D materials at high pressure. Scientists from Russia, Italy, the United ...

New study supports the effectiveness of the ForsythKids school-based dental program for reducing untreated tooth decay

New study supports the effectiveness of the ForsythKids school-based dental program for reducing untreated tooth decay
2021-03-31
In a longitudinal study published earlier this month in the Journal of the American Dental Association, researchers analyzed untreated decay in a cohort of nearly 7,000 children enrolled in the ForsythKids preventive dentistry program. Over the course of six years, the percentage of children with untreated cavities in the program decreased from 39 to 19 percent, suggesting that school-based prevention programs are effective in combating childhood dental disease. Tooth decay is the most common chronic early childhood disease in the United States. More than half of children aged 6-8 years old have had a cavity, and kids from low-income families ...

Scientists find genetic link to clogged arteries

Scientists find genetic link to clogged arteries
2021-03-31
High cholesterol is the most commonly understood cause of atherosclerosis, a hardening of the arteries that raises the risk of heart attack and stroke. But now, scientists at Washington University School of Medicine in St. Louis have identified a gene that likely plays a causal role in coronary artery disease independent of cholesterol levels. The gene also likely has roles in related cardiovascular diseases, including high blood pressure and diabetes. The study appears March 24 in the journal Science Translational Medicine. Studying mice and genetic data from people, the researchers found ...

Fast, portable test can diagnose COVID-19 and track variants

Fast, portable test can diagnose COVID-19 and track variants
2021-03-31
LA JOLLA--(March 31, 2021) Clinicians using a new viral screening test can not only diagnose COVID-19 in a matter of minutes with a portable, pocket-sized machine, but can also simultaneously test for other viruses--like influenza--that might be mistaken for the coronavirus. At the same time, they can sequence the virus, providing valuable information on the spread of COVID-19 mutations and variants. The new test, dubbed NIRVANA, was described online today by a multi-institution team of scientists in the journal Med. "This is a virus detection and surveillance method that doesn't require an expensive infrastructure like other approaches," says Juan Carlos Izpisua Belmonte, co-corresponding author and a professor in Salk's Gene Expression ...

OCD patients with comorbidities respond well to deep brain stimulation

2021-03-31
AURORA, Colo. (March 31, 2021) - A new study published in Frontiers in Psychiatry finds that patients with Obsessive Compulsive Disorder (OCD) as well as other psychiatric comorbidities, such as autism spectrum or tic disorders, may respond well to Deep Brain Stimulation (DBS). DBS is a minimally invasive neurosurgical procedure that uses coordinates to target certain areas of the brain, implanting electrodes that can help regulate abnormal brain activity. DBS procedures are rare for OCD in the United States; only a couple hundred patients have received this treatment for OCD management since its FDA approval ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Houston Methodist among largest providers of monoclonal antibody treatment for COVID-19
Strategy for successful mAB treatment program published in New England Journal of Medicine